{"SPADE_UN_17005": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17005", "Peptide Name": "435B peptide", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GPFHFYQFLFPPV", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "FITC", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C84H106N16O16", "Mass": 1595.84, "PI": 6.74, "Net Charge": 1, "Hydrophobicity": 0.46, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from Tat transduction domain.", "Pubmed ID": "17268054", "Reference": "Biol Pharm Bull. 2007 Feb;30(2)218-23.", "Author": "Kamada H, Okamoto T, Kawamura M, Shibata H, Abe Y, Ohkawa A, Nomura T, Sato M, Mukai Y, Sugita T, Imai S, Nagano K, Tsutsumi Y, Nakagawa S, Mayumi T, Tsunoda S.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17268054"}], "Frequent Amino Acids": "FPG", "Absent Amino Acids": "ACDEIKMNORSTUW", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 10, "Polar Residues": 4, "Positive Residues": 1, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02522", "Similarity": 0.75, "Sequence": "RFRPPIRRPPIRPPFRPPFRPPVRPPIRPPFRPPFRPPIGPFP"}, {"SPADE_ID": "SPADE_N_03221", "Similarity": 0.75, "Sequence": "RFRPPIRRPPIRPPFNPPFRPPVRPPFRPPFRPPFRPPIGPFP"}, {"SPADE_ID": "SPADE_N_13558", "Similarity": 0.75, "Sequence": "RFRPPILRPPIRPPFRPPFRPPVRPPIRPPFRPPFRPPIGPFP"}]}}}